APYX MEDICAL DL-,001APYX MEDICAL DL-,001APYX MEDICAL DL-,001

APYX MEDICAL DL-,001

No trades
See on Supercharts
Market capitalization
‪44.92 M‬EUR
−0.49EUR
‪−16.95 M‬EUR
‪47.43 M‬EUR
‪28.42 M‬
Beta (1Y)
0.80

About APYX MEDICAL DL-,001

CEO
Charles D. Goodwin
Headquarters
Clearwater
Employees (FY)
252
Founded
1978
ISIN
US03837C1062
FIGI
BBG00G75PK30
Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange APYX MEDICAL DL-,001 stocks are traded under the ticker BOV.
APYX MEDICAL DL-,001 is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for APYX MEDICAL DL-,001 has a max estimate of 7.37 EUR and a min estimate of 1.84 EUR.
BOV earnings for the last quarter are −0.12 EUR per share, whereas the estimation was −0.11 EUR resulting in a −14.04% surprise. The estimated earnings for the next quarter are −0.16 EUR per share. See more details about APYX MEDICAL DL-,001 earnings.
APYX MEDICAL DL-,001 revenue for the last quarter amounts to ‪11.33 M‬ EUR despite the estimated figure of ‪14.54 M‬ EUR. In the next quarter revenue is expected to reach ‪13.46 M‬ EUR.
Yes, you can track APYX MEDICAL DL-,001 financials in yearly and quarterly reports right on TradingView.
BOV net income for the last quarter is ‪−8.70 M‬ EUR, while the quarter before that showed ‪−4.38 M‬ EUR of net income which accounts for −98.77% change. Track more APYX MEDICAL DL-,001 financial stats to get the full picture.
No, BOV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BOV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade APYX MEDICAL DL-,001 stock right from TradingView charts — choose your broker and connect to your account.
BOV reached its all-time high on Aug 27, 2002 with the price of 59.50 EUR, and its all-time low was 1.09 EUR and was reached on Mar 25, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 252.00 employees. See our rating of the largest employees — is APYX MEDICAL DL-,001 on this list?
We've gathered analysts' opinions on APYX MEDICAL DL-,001 future price: according to them, BOV price has a max estimate of 7.37 EUR and a min estimate of 1.84 EUR. Read a more detailed APYX MEDICAL DL-,001 forecast: see what analysts think of APYX MEDICAL DL-,001 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. APYX MEDICAL DL-,001 EBITDA is ‪−17.45 M‬ EUR, and current EBITDA margin is −36.79%. See more stats in APYX MEDICAL DL-,001 financial statements.